This systematic review explores the multifaceted causes and treatments of androgenetic alopecia (AGA), emphasizing the importance of early and continuous therapy. It highlights the FDA-approved treatments—topical minoxidil and oral finasteride—while discussing additional therapeutic options targeting androgen activity, inflammation, prostaglandins, and genetic predisposition. The review encourages a personalized, combination-based approach for
